Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Gross Profit: 2020-2024

Historic Gross Profit for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $49.6 million.

  • Burning Rock Biotech's Gross Profit rose 0.65% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.5 million, marking a year-over-year increase of 4.94%. This contributed to the annual value of $49.6 million for FY2024, which is 2.96% down from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's Gross Profit is $49.6 million, which was down 2.96% from $51.2 million recorded in FY2023.
  • Burning Rock Biotech's 5-year Gross Profit high stood at $57.1 million for FY2021, and its period low was $48.1 million during FY2020.
  • In the last 3 years, Burning Rock Biotech's Gross Profit had a median value of $51.2 million in 2023 and averaged $52.0 million.
  • In the last 5 years, Burning Rock Biotech's Gross Profit rose by 18.77% in 2021 and then dropped by 7.15% in 2023.
  • Burning Rock Biotech's Gross Profit (MRY) stood at $48.1 million in 2020, then increased by 18.77% to $57.1 million in 2021, then fell by 3.57% to $55.1 million in 2022, then decreased by 7.15% to $51.2 million in 2023, then fell by 2.96% to $49.6 million in 2024.
  • Its Gross Profit stands at $49.6 million for FY2024, versus $51.2 million for FY2023 and $55.1 million for FY2022.